Form 4: Yield10 Bioscience CEO Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Oliver P. Peoples, CEO of Yield10 Bioscience, reports changes in beneficial ownership of company stock due to tax withholding and 401(k) contributions.

Summary

  • On August 15, 2024, Oliver P. Peoples, the President and CEO of Yield10 Bioscience, reported changes in his beneficial ownership of the company's stock.
  • 1,463 shares were withheld to cover withholding taxes upon the partial vesting of Restricted Stock Units (RSUs) granted on February 15, 2024.
  • Mr. Peoples also acquired 2,403 shares through the Yield10 Bioscience, Inc. 401(k) Plan as an issuer matching contribution.
  • Following these transactions, Mr. Peoples directly owns 12,634 shares of common stock and indirectly owns 2,403 shares through his 401(k) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and benefits, with no indication of significant positive or negative developments.

Positives

  • The acquisition of shares through the 401(k) plan indicates confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates standard transactions related to executive compensation and benefits.

Key Dates

DateDescription
02/15/2024Date of RSU grant
05/02/2024Reverse stock split (1:24) effected
08/15/2024Date of transaction (tax withholding and 401(k) contribution)
08/19/2024Date of Form 4 signature

Keywords

Yield10 Bioscience, Oliver P. Peoples, beneficial ownership, Form 4, stock, RSUs, 401(k)

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.